Chemotherapy Antitumor Intralymphatic

Antitumor intralymphatic chemotherapy

Chemotherapy is one of the main cancer treatments and is used to destroy malignant tumors in the body. One type of chemotherapy is antitumor intralymphatic chemotherapy, in which drugs are injected directly into the lymphatic vessels.

Intralymphatic chemotherapy is a regional form of treatment in which anti-cancer drugs are delivered directly to the tumor through the lymphatic system. Lymphatic vessels are an important component of our body and play a key role in transporting lymph, which contains cells of the immune system and other substances. Tumors typically have their own network of lymphatic vessels, and these can serve as a pathway for cancer cells to spread throughout the body.

The principle of intralymphatic chemotherapy is that drugs are injected directly into the lymphatic vessels that surround the tumor. This allows drugs to be delivered directly to the place where they are most needed, minimizing their impact on healthy tissues and organs. The procedure for introducing drugs into the lymphatic vessels can be done in a variety of ways, including intravenous administration, injections, or the use of special catheters.

Intralymphatic chemotherapy has its advantages and disadvantages. One of the main advantages is the more precise and local targeting of drugs to the tumor, which can lead to higher treatment effectiveness. In addition, this approach may reduce the systemic side effects that often occur with general chemotherapy. However, intralymphatic chemotherapy requires a more specialized procedure and may be limited to certain tumor types or stages of cancer.

Intralymphatic chemotherapy is used in combination with other cancer treatments such as surgery, radiation, and systemic chemotherapy. The decision to use this treatment method is made by the oncologist based on the individual characteristics of the patient and the characteristics of the tumor.

In conclusion, intralymphatic antitumor chemotherapy is one of the important cancer treatment methods. It is a regional form of chemotherapy in which drugs are injected directly into the lymphatic vessels surrounding the tumor. This approach allows drugs to be delivered directly to the tumor site, minimizing their effect on healthy tissue. Intralymphatic chemotherapy can be an effective treatment, but its use requires specialized procedures and is limited to certain types of tumors. The decision to use this method should be made by an oncologist, taking into account the individual characteristics of the patient and the characteristics of the tumor.

Antitumor intralymphatic chemotherapy is regional chemotherapy of tumors in which drugs are administered directly into the lymphatic vessels.

With this method, antitumor drugs enter the lymphatic system, bypassing the systemic bloodstream. This makes it possible to achieve a high concentration of chemotherapy directly at the tumor site and the involved lymph nodes. This approach provides maximum antitumor effect in the affected area and reduces the toxic effect on the entire body compared to systemic chemotherapy.

Intralymphatic administration of chemotherapy drugs is especially effective in the treatment of breast cancer, melanoma, penile cancer and other tumors that early metastasize to regional lymph nodes. This method allows you to destroy micrometastases in the lymphatic system in the early stages and thereby prevent further progression of the disease.